Voyager Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Voyager Therapeutics has a total shareholder equity of $236.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $351.3M and $115.0M respectively. Voyager Therapeutics's EBIT is $122.0M making its interest coverage ratio -10.4. It has cash and short-term investments of $230.9M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -10.4x |
Cash | US$230.88m |
Equity | US$236.32m |
Total liabilities | US$114.96m |
Total assets | US$351.28m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VT6's short term assets ($319.7M) exceed its short term liabilities ($64.5M).
Long Term Liabilities: VT6's short term assets ($319.7M) exceed its long term liabilities ($50.5M).
Debt to Equity History and Analysis
Debt Level: VT6 is debt free.
Reducing Debt: VT6 had no debt 5 years ago.
Debt Coverage: VT6 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: VT6 has no debt, therefore coverage of interest payments is not a concern.